Nicotinamide Adenine Dinucleotide (NAD+) is an essential coenzyme present in all living cells, vital for mitochondrial ATP generation, DNA repair through Poly(ADP-ribose) polymerases (PARPs), and deacetylase activation by Sirtuins (SIRT1-SIRT7). As endogenous NAD+ levels diminish by up to 50% between age 20 and 50, extracellular precursor supplementation has emerged as a primary longevity intervention.
NMN Transporter Slc12a8 vs NR Kinase Pathway
Nicotinamide Mononucleotide (NMN) utilizes the dedicated Slc12a8 intestinal transporter for rapid absorption directly into tissues, whereas Nicotinamide Riboside (NR) relies on extracellular conversion to NR via CD73 followed by intracellular phosphorylation by NRK1 and NRK2 enzymes.
Intravenous NAD+ Infusions vs Sublingual Bioavailability
While IV infusions rapidly elevate circulating extracellular plasma levels of NAD+, intact cellular uptake is limited due to the large molecular size of un-cleaved NAD+. Oral liposomal NMN demonstrates superior intracellular baseline accumulation over sustained 30-day trial periods.